[1]
Stein-Gold, L., Elewski, B., Draelos, Z. and Lin, T. 2020. Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 4, 1 (Jan. 2020), S9.